U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.307C>G (p.Pro103Ala) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 15, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001370713.7

Allele description [Variation Report for NM_000551.4(VHL):c.307C>G (p.Pro103Ala)]

NM_000551.4(VHL):c.307C>G (p.Pro103Ala)

Gene:
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.307C>G (p.Pro103Ala)
HGVS:
  • NC_000003.12:g.10142154C>G
  • NG_008212.3:g.5520C>G
  • NM_000551.4:c.307C>GMANE SELECT
  • NM_001354723.2:c.307C>G
  • NM_198156.3:c.307C>G
  • NP_000542.1:p.Pro103Ala
  • NP_000542.1:p.Pro103Ala
  • NP_001341652.1:p.Pro103Ala
  • NP_937799.1:p.Pro103Ala
  • LRG_322t1:c.307C>G
  • LRG_322:g.5520C>G
  • LRG_322p1:p.Pro103Ala
  • NC_000003.11:g.10183838C>G
  • NM_000551.3:c.307C>G
Protein change:
P103A
Links:
dbSNP: rs864622267
NCBI 1000 Genomes Browser:
rs864622267
Molecular consequence:
  • NM_000551.4:c.307C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354723.2:c.307C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198156.3:c.307C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chuvash polycythemia
Synonyms:
POLYCYTHEMIA, VHL-DEPENDENT; Erythrocytosis, familial, 2
Identifiers:
MONDO: MONDO:0009892; MedGen: C1837915; Orphanet: 238557; OMIM: 263400
Name:
Von Hippel-Lindau syndrome (VHLS)
Synonyms:
VHL syndrome; Von Hippel-Lindau
Identifiers:
MONDO: MONDO:0008667; MedGen: C0019562; Orphanet: 892; OMIM: 193300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001567241Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 15, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene.

Kim L, Holland AJ, Srinivasan S, Cowell CT, Benn DE, Robinson BG.

J Paediatr Child Health. 2008 Sep;44(9):514-6. doi: 10.1111/j.1440-1754.2008.01360.x.

PubMed [citation]
PMID:
18928468

Mutation screening in a Norwegian cohort with pheochromocytoma.

Sjursen W, Halvorsen H, Hofsli E, Bachke S, Berge A, Engebretsen LF, Falkmer SE, Falkmer UG, Varhaug JE.

Fam Cancer. 2013 Sep;12(3):529-35. doi: 10.1007/s10689-013-9608-0.

PubMed [citation]
PMID:
23407919
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001567241.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Pro103 amino acid residue in VHL. Other variant(s) that disrupt this residue have been observed in individuals with VHL-related conditions (PMID: 18928468, 23407919, 30877234), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VHL protein function. ClinVar contains an entry for this variant (Variation ID: 219823). This variant has been observed in individual(s) with pheocromocytoma (PMID: 21463266). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with alanine at codon 103 of the VHL protein (p.Pro103Ala). The proline residue is moderately conserved and there is a small physicochemical difference between proline and alanine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024